Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
Kite, a Gilead Company (Nasdaq: GILD), presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with ...
Kite, a Gilead Company, has presented new findings demonstrating the safety, efficacy and quality of life benefits offered by ...
A seventh person has been ‘cured’ of the HIV through a stem cell transplant. But the treatment can only be used for people with fatal cancers as it is very risky to be attempted in people without ...
SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...
November marks National Family Caregivers Month, honoring the nearly one in four U.S. adultswho provide essential, often unpaid care — a strain particularly acute in Florida, where 4.45 million adults ...
The code of life is now editable and the question humanity must answer in the 2020s is not whether we can rewrite it—but whether we should, and for whom.
In this interview, Alastair Carrington, director at Atelerix, outlines how hydrogel-based preservation technology can enable ...
In response to the stringent requirements for safety, durability, and cost-effectiveness in home applications, Dongfang Boiler has successfully developed and manufactured a 1kW fuel cell CHP system ...
Our staff and contributors look back on a year in art, from museum reopenings to shows that make and remake history.
Single-atom transition metal-nitrogen-doped carbons (SA M-N-Cs) catalysts are promising alternatives to platinum-based ...
Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback